BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
Metropolitan Greatness: The 6 Urban areas for Quality Living in 2024 - 2Holiday season sees uptick in norovirus cases, according to CDC
- 3The most effective method to Quick Track Your Outcome in Advanced Showcasing with a Web-based Degree
- 4A Manual for Pick High Evaluated Food Conveyance Administrations In Significant Urban communities For 2024
- 5I'm an 83-year-old yoga instructor. I'm not your typical grandma — I still work to feel fulfilled and supplement my Social Security.
- Top 5 Top of the line Books of the Year
- Hundreds of kilos of protected plant seized by Israel Nature and Parks Authority in Golan
- Check out the exclusive pitch deck Valerie Health used to raise $30 million from Redpoint Ventures to automate healthcare faxes
- Corcept Therapeutics shares surge as lead drug gets FDA nod for ovarian cancer
- One of the best meteor showers of the year peaks at the worst possible time this week
- We analyzed Philly street scenes and identified signs of gentrification using machine learning trained on longtime residents’ observations
- Find the Advantages of Positive Nurturing: Supporting Cheerful and Sound Kids
- Building an Individual Brand: Illustrations from Forces to be reckoned with
- Fossil analysis changes what paleontologists know about how long T. rex took to grow full size
